Company intelligence / Profile preview
Ultramark Healthcare
- Ownership
- Private
- Development stage
- Other
Overview
Ultramark Healthcare manufactures, markets, and exports a broad range of pharmaceuticals, herbal, and nutraceutical products, including tablets, injections, ointments, and natural health supplements. Their products are marketed internationally and generally positioned as safe, high-quality, and natural, with a focus on stringent quality assurance.
- Therapeutic areas
- Metabolic DisordersRheumatologyDermatologyCardiovascularOtherNeurology
- Modalities
- Small moleculeBiologicHerbal product
- Industry
- Biotech
Drug pipeline
1 assetBeyond the preview
Go deeper on Ultramark Healthcare.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Ultramark Healthcare.